Chinese Journal of Cancer Biotherapy
Published by Editorial office of Chinese Journal of Cancer Biotherapy
ISSN : 1007-385X
Abbreviation : Chin. J. Cancer Biotherapy
Aims & Scope
Chinese Journal of Cancer Biotherapy (CJCB, ISSN 1007-385X, CN 31-1725/R) is co-sponsored by Chinese Immunology Association and Chinese Anti-cancer Association and founded in 1994.
Being the only journal in its field in China, CJCB is listed as a national core journal and a source journal of Chinese Scientific Article Index.
CJCB is an open access journal, published very two months.
The columns of CJCB include commentary, academician forum, expert forum, original article (basic and clinical research article), prompt report, case report, review article, etc.
The target readers of CJCB include clinicians and researchers involved in tumor prevention and treatment, teachers and students of medical institutions, and other relevant researchers.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.108 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q4 |
h-index
| Year | Value |
|---|---|
| 2024 | 5 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 28763 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 33 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.